Device saturation
Is Sofwave Saturated in Pennsylvania?
Ask Paige tracks 19 practices running Sofwave in Pennsylvania, averaging 4.8★ on Google — about 1.8% of all tracked practices statewide. Compiled from proprietary intelligence gathered by Fathom's collection engine, not manufacturer install figures.
Pennsylvania runs Sofwave at a higher rate than the national average — this market leans toward already saturated.
FDA clearance
510(k) K231537 — Sofwave Medical, Ltd.. Cleared for: General, Plastic Surgery; Summary.
Treatments paired with Sofwave in Pennsylvania
| Name | Count | Percent | You offer |
|---|---|---|---|
| RF Microneedling | 12 | 63.2% | no |
| Botox / Neurotoxin | 12 | 63.2% | no |
| Dermal Filler | 11 | 57.9% | no |
| Chemical Peel | 10 | 52.6% | no |
| Laser Hair Removal | 8 | 42.1% | no |
| Body Contouring | 7 | 36.8% | no |
| Skin Tightening | 6 | 31.6% | no |
| PRP / PRF | 6 | 31.6% | no |
| Vaginal Rejuvenation | 6 | 31.6% | no |
| Porcelain Veneers | 6 | 31.6% | no |
Frequently asked
How many practices in Pennsylvania have Sofwave?
Ask Paige tracks 19 practices running Sofwave in Pennsylvania, about 1.8% of all tracked practices in the state.
Is Sofwave saturated in Pennsylvania?
Pennsylvania runs Sofwave at a higher rate than the national average — this market leans toward already saturated.
Does Sofwave have FDA clearance?
FDA 510(k) K231537, cleared for Sofwave Medical, Ltd.. Cleared indications: General, Plastic Surgery; Summary.
What treatments is Sofwave typically used for?
In Ask Paige's corpus, practices running Sofwave most often pair it with: Skin Tightening.
See if Sofwave pencils out for your practice in Pennsylvania.
See how your practice compares against Ask Paige's proprietary practice intelligence — devices, services, ratings, and demand, side by side with yours.
Start free trial30-day pilot, the Rep-Meeting Test (card required to start; no charge if you cancel within 30 days), then $99/month founding rate for the first 100 practices or $199/month standard rate. Cancel anytime.